1. Home
  2. QURE vs ACHC Comparison

QURE vs ACHC Comparison

Compare QURE & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uniQure N.V.

QURE

uniQure N.V.

N/A

Current Price

$24.11

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Logo Acadia Healthcare Company Inc.

ACHC

Acadia Healthcare Company Inc.

N/A

Current Price

$37.87

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QURE
ACHC
Founded
1998
2005
Country
Netherlands
United States
Employees
248
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
QURE
ACHC
Price
$24.11
$37.87
Analyst Decision
Strong Buy
Buy
Analyst Count
13
14
Target Price
★ $59.78
$39.07
AVG Volume (30 Days)
1.7M
★ 2.2M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 29.67
N/A
EPS
N/A
★ 0.54
Revenue
$13,107,000.00
★ $3,312,769,000.00
Revenue This Year
$44.21
$4.17
Revenue Next Year
$398.45
$6.10
P/E Ratio
★ N/A
$70.41
Revenue Growth
N/A
★ 5.04
52 Week Low
$8.73
$11.43
52 Week High
$51.72
$39.70

Technical Indicators

Market Signals
Indicator
QURE
ACHC
Relative Strength Index (RSI) 46.32 71.86
Support Level $20.63 $26.70
Resistance Level $26.01 N/A
Average True Range (ATR) 1.93 1.99
MACD 0.68 0.68
Stochastic Oscillator 57.62 81.27

Price Performance

Historical Comparison
QURE
ACHC

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

About ACHC Acadia Healthcare Company Inc.

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.

Share on Social Networks: